These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7710759)

  • 1. Expression of surrogate light chain in common variable immunodeficiency.
    Yano M; Kondo N; Kato Y; Shinoda S; Inoue R; Orii T
    Exp Clin Immunogenet; 1995; 12(1):1-9. PubMed ID: 7710759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.
    Okabe T; Bauer SR; Kudo A
    Eur J Immunol; 1992 Jan; 22(1):31-6. PubMed ID: 1730257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell development in mice with a defective lambda 5 gene.
    Rolink A; Karasuyama H; Grawunder U; Haasner D; Kudo A; Melchers F
    Eur J Immunol; 1993 Jun; 23(6):1284-8. PubMed ID: 7684685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
    Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
    J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VpreB gene in common variable immunodeficiency.
    Kato Y; Kondo N; Yano M; Inoue R; Ozawa T; Orii T
    Exp Clin Immunogenet; 1994; 11(1):53-8. PubMed ID: 8031574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surrogate light chain in B-cell development.
    Melchers F; Karasuyama H; Haasner D; Bauer S; Kudo A; Sakaguchi N; Jameson B; Rolink A
    Immunol Today; 1993 Feb; 14(2):60-8. PubMed ID: 8166770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
    Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
    J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression.
    Guelpa-Fonlupt V; Tonnelle C; Blaise D; Fougereau M; Fumoux F
    Eur J Immunol; 1994 Jan; 24(1):257-64. PubMed ID: 8020565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of surrogate light chain (psi L) in the absence of mu on human pro-B cell lines and normal pro-B cells.
    Meffre E; Fougereau M; Argenson JN; Aubaniac JM; Schiff C
    Eur J Immunol; 1996 Sep; 26(9):2172-80. PubMed ID: 8814264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene conversion events contribute to the polymorphic variation of the surrogate light chain gene lambda 5/14.1.
    Conley ME; Rapalus L; Boylin EC; Rohrer J; Minegishi Y
    Clin Immunol; 1999 Nov; 93(2):162-7. PubMed ID: 10527692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
    Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
    Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire.
    Milili M; Le Deist F; de Saint-Basile G; Fischer A; Fougereau M; Schiff C
    J Clin Invest; 1993 Apr; 91(4):1616-29. PubMed ID: 8473505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
    Licence S; Persson C; Mundt C; Mårtensson IL
    Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of VpreB-3 under the control of the immunoglobulin heavy chain enhancer and SV40 promoter.
    Hagiwara S
    Kobe J Med Sci; 1996 Feb; 42(1):43-59. PubMed ID: 8984229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.